[go: up one dir, main page]

Soybilgic et al., 2013 - Google Patents

Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

Soybilgic et al., 2013

View HTML @Full View
Document ID
5953822020141476038
Author
Soybilgic A
Onel K
Utset T
Alexander K
Wagner-Weiner L
Publication year
Publication venue
Pediatric Rheumatology

External Links

Snippet

Background Women with SLE have higher rates of persistent human papilloma virus (HPV) infections and precancerous lesions than healthy women. HPV vaccine is safe and effective in healthy females aged 9–26 years. There are limited data on the safety and …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Soybilgic et al. Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years
Malard et al. Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
Altintas et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura
Rasti et al. ToRCH “co‐infections” are associated with increased risk of abortion in pregnant women
Cattaneo et al. Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab
Lin et al. Childhood vitiligo in China: clinical profiles and immunological findings in 620 cases
Ng et al. Screening for family members of patients with nasopharyngeal carcinoma
Ma et al. Subclinical impairment of ovarian reserve in systemic lupus erythematosus patients with normal menstruation not using alkylating therapy
Sherkat et al. Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss
Patsatsi et al. Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid
Moe et al. Association of hepatitis C virus infection with prevalence and development of kidney disease
Zhou et al. Comparative study of indirect immunofluorescence, enzyme‐linked immunosorbent assay, and the Tzanck smear test for the diagnosis of pemphigus
Su et al. Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysis
Park et al. Relationships of varicella zoster virus (VZV)‐specific cell‐mediated immunity and persistence of VZV DNA in saliva and the development of postherpetic neuralgia in patients with herpes zoster
Depuydt et al. SARS-CoV-2 infection reduces quality of sperm parameters: prospective one year follow-up study in 93 patients
Tanskanen et al. Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases
Vuitton et al. A plea for the pathogenic role of immune complexes in severe Covid-19
Ishimori et al. Influenza virus vaccination in pediatric nephrotic syndrome significantly reduces rate of relapse and influenza virus infection as assessed in a nationwide survey
Freund et al. Interactions and clinical implications of serological and respiratory variables 3 months after acute COVID-19
Catzola et al. Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis
Tuerxun et al. Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China
Tanaka et al. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis
Sun et al. Clinical characteristics and prognosis of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseases in China
Bhatla et al. Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine
Dillner et al. Antibodies to SARS-CoV-2 and risk of past or future sick leave